Lonza is an integrated solutions provider and a pharmaceutical supplier that is going to have a new CEO at the end of 2020. As known, 2019...
Each year, MIT Technology Review selects the top 35 technological talents under the age of 35 in Europe. The covered fields are biotechnology, nanotechnology, electronics, robotics,...
Last year, German biotechnology companies raised approximately $957 million (€860 million) in capital from venture capital and capital increases via the stock exchange. This included two...
Argenx is a biotechnological company that develops antibody-based drugs. The company is planning to become a global immunology company in 2021, as its liquid assets have...
Pharmaceutical companies have become an important part of the Spanish economy. Companies in this sector had a strong year and some were able to triple their...
The small synthetic biology company “Syngulon” develops technologies based on bacteriocins, natural molecule properties which are of interest to several industrial sectors. It has just signed...
BioNTech is a biotechnology company that is working towards revolutionary new cancer treatment methods. The company is headquartered in the upper city of Mainz and has...
In the biotechnology sector, buyouts and licensing agreements are almost always accompanied by development milestones and other milestone payments. Analysts have attempted to quantify the share...
The Mainz-based company BioNTech develops individualized cancer drugs. The company has raised billions of U.S. dollars on the U.S. technology exchange Nasdaq. BioNtech is a rarity,...
The Liège-based biotech company PDC*line Pharma, which specializes in immuno-oncology, has initiated a Phase I/II study to evaluate a therapeutic vaccine against lung cancer. This cancer...